SEC Filings for Ligand Pharmaceuticals Incorporated (LGND)

$ 106.73   2.04 (+1.95%) Volume: 101.39k 10:00 AM EDT Sep 20, 2019
Filing Type:
Form TypeForm DescriptionPagesDateView
4Statement of changes in beneficial ownership of securities106/07/2019
4Statement of changes in beneficial ownership of securities106/07/2019
DEFA14AAdditional proxy soliciting materials - definitive206/04/2019
8-KReport of unscheduled material events or corporate changes.406/03/2019
4Statement of changes in beneficial ownership of securities105/31/2019
4Statement of changes in beneficial ownership of securities105/31/2019
8-KReport of unscheduled material events or corporate changes.405/24/2019
4Statement of changes in beneficial ownership of securities105/22/2019
4Statement of changes in beneficial ownership of securities105/16/2019
4Statement of changes in beneficial ownership of securities105/14/2019
4Statement of changes in beneficial ownership of securities105/14/2019
10-QQuarterly report with a continuing view of a company's financial position3805/09/2019
8-KReport of unscheduled material events or corporate changes.1405/02/2019
DEFA14AAdditional proxy soliciting materials - definitive204/24/2019
DEF 14AOfficial notification to shareholders of matters to be brought to a vote (Proxy)9704/24/2019
123456789101112131415